5e), but to determine the persistence of agonistreceptor complexes, we adapted our TR-FRET binding assay to include reversible labeling using cleavable SNAP-biotin complexed to streptavidin-terbium to label the surface GLP-1Rs and, after internalization with different FITC-agonists, stripping residual surface receptors of label to ensure that FRET was derived only from internalized receptors (see Fig
Exploring non-injectable formulations: Many adolescents prefer oral medications, driving research into oral GLP-1RA formulations
References Palmer SC, Tendal B, Mustafa RA et al (2021) Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials
Lancet 398 , 262276 (2021)
But, from my perspective, knowing that treatments exist right now that help you obtain a healthy weight, why expose yourself to unneeded risk